Literature DB >> 31126930

Primary aldosteronism associated with a germline variant in CACNA1H.

Kendra Wulczyn1, Edward Perez-Reyes2, Robert L Nussbaum3, Meyeon Park1.   

Abstract

The CACNA1H gene encodes the pore-forming α1 subunit of the T-type voltage-dependent calcium channel CaV3.2, expressed abundantly in the adrenal cortex. Mutations in CACNA1H are associated with various forms of primary aldosteronism (PA), including familial hyperaldosteronism type 4 (FH4). We describe a patient with refractory hypokalaemia and elevated aldosterone secretion independent of renin activity. Despite the absence of overt hypertension in this patient, the laboratory evaluation was consistent with a diagnosis of PA. Whole-exome sequencing revealed a de novo missense variant, R890H, in the voltage sensing domain of CACNA1H Expression of the variant channel in cells resulted in decreased whole-cell current, consistent with a loss-of-function. We hypothesise this variant is the genetic cause of pathological aldosterone secretion in this patient, and thereby expand the current understanding of the genetic basis of FH4. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adrenal disorders; fluid electrolyte and acid–base disturbances; genetics

Mesh:

Substances:

Year:  2019        PMID: 31126930      PMCID: PMC6536178          DOI: 10.1136/bcr-2018-229031

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  [Hypertension caused by tumors of the adrenal cortex].

Authors:  M LITYNSKI
Journal:  Pol Tyg Lek (Wars)       Date:  1953-02-09

2.  ACTH induces Cav3.2 current and mRNA by cAMP-dependent and cAMP-independent mechanisms.

Authors:  Haiyan Liu; Judith A Enyeart; John J Enyeart
Journal:  J Biol Chem       Date:  2010-04-27       Impact factor: 5.157

Review 3.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 4.  Old and New Concepts in the Molecular Pathogenesis of Primary Aldosteronism.

Authors:  Elke Tatjana Aristizabal Prada; Jacopo Burrello; Martin Reincke; Tracy Ann Williams
Journal:  Hypertension       Date:  2017-10-03       Impact factor: 10.190

5.  The changing clinical spectrum of primary aldosteronism.

Authors:  E L Bravo; R C Tarazi; H P Dustan; F M Fouad; S C Textor; R W Gifford; D G Vidt
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

6.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice.

Authors:  Silvia Monticone; Jacopo Burrello; Davide Tizzani; Chiara Bertello; Andrea Viola; Fabrizio Buffolo; Luisa Gabetti; Giulio Mengozzi; Tracy A Williams; Franco Rabbia; Franco Veglio; Paolo Mulatero
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

7.  Evidence of primary aldosteronism in a predominantly female cohort of normotensive individuals: a very high odds ratio for progression into arterial hypertension.

Authors:  Athina Markou; Theodora Pappa; Gregory Kaltsas; Aggeliki Gouli; Kostas Mitsakis; Panayiotis Tsounas; Anastasia Prevoli; Vaios Tsiavos; Labrini Papanastasiou; George Zografos; George P Chrousos; George P Piaditis
Journal:  J Clin Endocrinol Metab       Date:  2013-03-07       Impact factor: 5.958

8.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

Review 9.  Genetic Causes of Functional Adrenocortical Adenomas.

Authors:  Maria-Christina Zennaro; Sheerazed Boulkroun; Fabio Fernandes-Rosa
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

10.  Continuum of Renin-Independent Aldosteronism in Normotension.

Authors:  Rene Baudrand; Francisco J Guarda; Carlos Fardella; Gregory Hundemer; Jenifer Brown; Gordon Williams; Anand Vaidya
Journal:  Hypertension       Date:  2017-03-13       Impact factor: 10.190

View more
  5 in total

1.  Monogenic forms of low-renin hypertension: clinical and molecular insights.

Authors:  Priyanka Khandelwal; Jaap Deinum
Journal:  Pediatr Nephrol       Date:  2021-08-20       Impact factor: 3.651

Review 2.  Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.

Authors:  Lucas S Santana; Augusto G Guimaraes; Madson Q Almeida
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

Review 3.  Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies.

Authors:  Jörg Striessnig
Journal:  Front Synaptic Neurosci       Date:  2021-03-03

Review 4.  Genetics of Primary Aldosteronism.

Authors:  Ute I Scholl
Journal:  Hypertension       Date:  2022-02-10       Impact factor: 10.190

Review 5.  Molecular Mechanisms of Primary Aldosteronism.

Authors:  Sergei G Tevosian; Shawna C Fox; Hans K Ghayee
Journal:  Endocrinol Metab (Seoul)       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.